China Pharma (NYSE:CPHI) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of China Pharma (NYSE:CPHI) in a research report report published on Monday morning. The firm issued a hold rating on the stock.

China Pharma Stock Performance

CPHI stock opened at $0.31 on Monday. China Pharma has a 12 month low of $0.27 and a 12 month high of $2.18. The company has a current ratio of 0.88, a quick ratio of 0.33 and a debt-to-equity ratio of 0.19. The company has a fifty day moving average price of $0.35 and a 200 day moving average price of $0.45.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.